Technology News and Research

RSS

ONR-sponsored study explores cause of extreme fatigue in Navy divers

To determine the cause of extreme fatigue in Navy divers after routine missions, the Office of Naval Research (ONR) is sponsoring work examining the most critical weapon in a diver's arsenal--oxygen itself.

23 Dec 2015

Innovative quadcopter drone could help spot cancer cells

The imaging skills that undergraduates in Duquesne University's biomedical engineering program used to develop a pothole-detecting drone now are being applied to spotting cancer cells.

23 Dec 2015

Dynamic light scattering technique may help detect people at risk of cataracts and presbyopia

As we age, proteins in the lenses of our eyes start misbehaving: They unfold and congregate in clusters that block, scatter and distort light as it passes through the lens. A cloudy area, or cataract, forms. In a new study, scientists found that throughout our lifetime, levels of a key protein decline, and may be an early warning sign of a developing cataract.

23 Dec 2015

NUS scientists uncover mystery behind potent parasite-killing effect of artemisinin

A team of researchers from the National University of Singapore has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.

23 Dec 2015

New $8.5M research grant aims to address patients affected by severe hemophilia A

People with hemophilia have prolonged abnormal bleeding as a result of trauma. Hemophilia A, also called factor VIII (FVIII) deficiency, is the most common form of the genetic disorder caused by missing or defective blood clotting protein called factor VIII.

23 Dec 2015

New footage shows how AIDS vaccine candidate recruits immune cells to destroy infected cells

Using innovative technology, scientists from the Institut Pasteur and Inserm have filmed in vivo the process by which an AIDS vaccine candidate, developed by the French Vaccine Research Institute and the ANRS, triggers the immune response.

23 Dec 2015

Researchers describe epigenetic mechanisms underlying the development of cerebellum

From before birth through childhood, connections form between neurons in the brain, ultimately making us who we are. So far, scientists have gained a relatively good understanding of how neural circuits become established, but they know less about the genetic control at play during this crucial developmental process.

23 Dec 2015

UMass Medical School and UMass Lowell collaborate on new cyberinfrastructure technology to improve health care

Researchers at UMass Medical School and UMass Lowell are collaborating on a new cyberinfrastructure technology that will enable patients, researchers and physicians to transport and store large quantities of data, including sensitive information, through a secure system.

23 Dec 2015

Government officials attend press conference announcing international healthcare service session at 4th CIFTIS

A press conference announcing the hosting of the International Healthcare Service session at the 4th China Beijing International Fair for Trade in Services (CIFTIS), which was co-organized by CiMing Health Checkup Management Group, was held in Beijing on December 18th, 2015.

23 Dec 2015

SuperCom signs definitive agreement to acquire Leaders in Community Alternatives

SuperCom, a global provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced today that it has entered into a definitive agreement to acquire Leaders in Community Alternatives, Inc., a California-based criminal justice organization providing electronic monitoring and community-based services under contracts with various government agencies.

22 Dec 2015

Bern study sheds light on the brain mechanism of arousal

Scientists from Bern have discovered a mechanism which is responsible for the rapid arousal from sleep and anesthesia in the brain. The results of their study suggest new strategies for the medical treatment of sleep disorders and recovery of consciousness in vegetative states.

22 Dec 2015

Baxalta announces initial results from ADYNOVATE Phase 3 trial for treatment of hemophilia patients

Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today announced initial results from a Phase 3 clinical trial of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], an extended circulating half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

22 Dec 2015

Forge Therapeutics obtains exclusive license to patent rights related to novel metalloprotein inhibitors

Forge Therapeutics, Inc., a biotechnology company developing innovative medicines using a breakthrough drug discovery platform targeting metalloproteins, announced today it has obtained an exclusive license from the University of California San Diego to patent rights related to novel metalloprotein inhibitors discovered in the laboratory of Forge Therapeutics scientific co-founder Professor Seth Cohen, Ph.D.

22 Dec 2015

New MRI-based technology could help identify patients at risk of recurrent stroke

Patients who have had a stroke in the back of the brain are at greater risk of having another within two years if blood flow to the region is diminished, according to results of a multicenter study led by researchers at the University of Illinois at Chicago.

22 Dec 2015

New drug approved by FDA for treatment of von Willebrand disease

"VONVENDI [von Willebrand factor (Recombinant)]", the new drug from Baxalta Incorporated, a global biopharmaceutical company recently spun off from Baxter International, has just been approved by the United States Food and Drug Administration.

22 Dec 2015

Email communications between patients, physicians improve overall health

A third of patients with chronic conditions who exchanged secure emails with their doctors said that these communications improved their overall health, according to a Kaiser Permanente study published today in the American Journal of Managed Care.

22 Dec 2015

Small airway-on-a-chip enables analysis of human COPD and asthma

A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.

22 Dec 2015

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Alexza Pharmaceuticals, Inc. today announced interim results of its Phase 2a study of AZ-002 (Staccato alprazolam) in epilepsy patients. AZ-002 produced a dose-related decrease in mean Standardized Photosensivity Range (SPR), the primary endpoint in the study.

21 Dec 2015

Aquinnah secures $5 million private equity investment from Takeda

Aquinnah Pharmaceuticals announced today that it has received a $5 Million investment from Takeda Pharmaceutical Company, Limited, in it's first private equity financing. The company has assembled a world-class team of drug developers and an exceptional Scientific Advisory Board in the fields of Amyotrophic Lateral Sclerosis (ALS), protein and RNA regulation, and neurodegenerative diseases.

21 Dec 2015

New survey shows how patients, pharmacists benefit from med sync programs

A recent survey of National Community Pharmacists Association member pharmacies utilizing NCPA's Simplify My Meds (SMM) program documented how both patients and pharmacists benefit from medication synchronization programs, or "med sync."

21 Dec 2015

Technology News and Research

ONR-sponsored study explores cause of extreme fatigue in Navy divers

Innovative quadcopter drone could help spot cancer cells

Dynamic light scattering technique may help detect people at risk of cataracts and presbyopia

NUS scientists uncover mystery behind potent parasite-killing effect of artemisinin

New $8.5M research grant aims to address patients affected by severe hemophilia A

New footage shows how AIDS vaccine candidate recruits immune cells to destroy infected cells

Researchers describe epigenetic mechanisms underlying the development of cerebellum

UMass Medical School and UMass Lowell collaborate on new cyberinfrastructure technology to improve health care

Government officials attend press conference announcing international healthcare service session at 4th CIFTIS

SuperCom signs definitive agreement to acquire Leaders in Community Alternatives

Bern study sheds light on the brain mechanism of arousal

Baxalta announces initial results from ADYNOVATE Phase 3 trial for treatment of hemophilia patients

Forge Therapeutics obtains exclusive license to patent rights related to novel metalloprotein inhibitors

New MRI-based technology could help identify patients at risk of recurrent stroke

New drug approved by FDA for treatment of von Willebrand disease

Email communications between patients, physicians improve overall health

Small airway-on-a-chip enables analysis of human COPD and asthma

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Aquinnah secures $5 million private equity investment from Takeda

New survey shows how patients, pharmacists benefit from med sync programs

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News